Manidipine is a dihydropyridine calcium channel blocker primarily used in the management of hypertension. To ensure the safety and efficacy of this medication, pharmaceutical laboratories rely on a comprehensive… Read more


![Chemical structure of 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-Pyridinedicarboxylic Acid 2-[4-(diphenylmethyl)-1-piperazinyl]ethyl Ethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F89226-51-7-14-Dihydro-26-dimethyl-4-3-nitrophenyl-35-Pyridinedicarboxylic-Acid-2-4-diphenylmethyl-1-piperazinylethyl-Ethyl-Ester.png&w=3840&q=75)

![Chemical structure of 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-Pyridinedicarboxylic Acid 3-[2-[4-(diphenylmethyl)-1-piperazinyl]ethyl] 5-methyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F104305-93-3-26-Dimethyl-4-3-nitrophenyl-35-Pyridinedicarboxylic-Acid-3-2-4-diphenylmethyl-1-piperazinylethyl-5-methyl-Ester.png&w=3840&q=75)



![Chemical structure of 2-[4-(Diphenylmethyl)piperazin-1-yl]ethanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F10527-64-7-2-4-Diphenylmethylpiperazin-1-ylethanol.png&w=3840&q=75)











Manidipine is a dihydropyridine calcium channel blocker primarily used in the management of hypertension. To ensure the safety and efficacy of this medication, pharmaceutical laboratories rely on a comprehensive range of reference standards, including the active pharmaceutical ingredient, known impurities, and stable isotope labelled compounds. These materials are essential for rigorous impurity profiling, method validation, and routine quality control testing. By utilizing high-quality reference standards—such as synthetic intermediates, degradation products, and specific process-related impurities—scientists can accurately detect and quantify trace substances during stability studies and analytical method development. The availability of stable isotope labelled standards further facilitates precise mass spectrometry analysis, enabling researchers to maintain strict compliance with regulatory guidelines during the development and manufacturing of pharmaceutical products.